• Phase

    Alumni community member

  • Contact person

    Kåre Engkilde, CEO

  • Email

    ke@longboatamniotics.com

  • Area

    Pharma & Biotech

Longboat Amniotics

Longboat Amniotics AB is a company primarily within stem cell therapeutics. We provide a novel platform for the production of medically superior mesenchymal stem cells (MSC’s) including ethical and medically sound biobanking opportunities for the newborn. Moreover, our field of operation includes enhancement of hematological stem cell development, pluripotent stem cell technologies and novel lung protective compounds.

© Copyright SmiLe Incubator